Schedule 13D ownership disclosure
Anteris Technologies Global Corp
Common Stock · CUSIP: 03675P102
Event date: 2026-01-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Medtronic plcReported CIK 0001613103
Shares: 15,652,173.00 · Class: 16.2%
- Covidien Group S.a.r.l.Reported CIK 0001463363
Shares: 15,652,173.00 · Class: 16.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-26-002429
- Form type
- SCHEDULE 13D
- Filer
- Anteris Technologies Global Corp.
- CIK
- CIK 2011514
- Filed
- Jan 29, 2026
- Reporting period
- Jan 22, 2026
- Description
- Schedule 13D beneficial ownership